Comparative absorption of a standardized curcuminoid mixture and its lecithin formulation

Area of Science:

• Pharmacokinetics
• Nutraceuticals
• Natural Product Chemistry

Background:

• Curcuminoids are known for potential anti-inflammatory properties but suffer from poor bioavailability.
• Lecithin formulations aim to improve the absorption of poorly soluble compounds like curcuminoids.

Purpose of the Study:

• To compare the relative absorption of a standardized curcuminoid mixture versus its lecithin formulation (Meriva) in humans.
• To evaluate plasma levels and profiles of major curcuminoids after administration of both formulations.

Main Methods:

• A randomized, double-blind, crossover human study design was employed.
• Clinically validated dosages of both unformulated curcuminoids and Meriva were administered.
• Plasma concentrations of curcumin (1a), demethoxycurcumin (1b), and bisdemethoxycurcumin (1c) were quantified.

Main Results:

• Meriva demonstrated approximately 29-fold higher total curcuminoid absorption compared to the unformulated mixture.
• Phospholipid formulation preferentially increased absorption of demethoxylated curcuminoids (1b, 1c) over curcumin (1a).
• The primary circulating curcuminoid with Meriva was demethoxycurcumin (1b), a more potent analogue in vitro.

Conclusions:

• Lecithin formulation (Meriva) significantly enhances curcuminoid bioavailability.
• The altered plasma curcuminoid profile, with higher demethoxycurcumin levels, may contribute to Meriva's clinical efficacy at lower doses.
• Further research is needed as detected plasma concentrations were below those typically required for potent anti-inflammatory targets.